End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.645 MYR | +1.57% | +2.38% | +3.20% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The firm trades with high earnings multiples: 23.04 times its 2024 earnings per share.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.20% | 73.94M | - | ||
+20.68% | 85.55B | C+ | ||
-29.31% | 70.07B | B- | ||
+6.97% | 28.95B | C+ | ||
-8.63% | 17.51B | B | ||
+2.14% | 17.39B | A- | ||
+0.39% | 15.38B | A- | ||
+6.47% | 13.4B | B- | ||
+68.09% | 12.93B | C- | ||
+5.35% | 12.77B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- OPTIMAX Stock
- Ratings Optimax Holdings